CD8A and melanoma: In the context of melanoma, studies have shown that while the presence of intratumoral lymphocytes is generally a positive prognostic factor, inspecting individual populations using markers such as CD3 or CD8, or activated T cells, may yield conflicting results in smaller cohorts of patients (30, 33).